Quercioli L - Search Results

1

Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder.

Koran LM, Pallanti S, Paiva RS, Quercioli L. Koran LM, et al. Among authors: quercioli l. Eur Neuropsychopharmacol. 1998 May;8(2):121-6. doi: 10.1016/s0924-977x(97)00048-5. Eur Neuropsychopharmacol. 1998. PMID: 9619690 Free article. Clinical Trial.

2

Citalopram for treatment-resistant obsessive-compulsive disorder.

Pallanti S, Quercioli L, Paiva RS, Koran LM. Pallanti S, et al. Among authors: quercioli l. Eur Psychiatry. 1999 Apr;14(2):101-6. doi: 10.1016/s0924-9338(99)80725-1. Eur Psychiatry. 1999. PMID: 10572334 Clinical Trial.

3

Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.

Koran LM, Pallanti S, Quercioli L. Koran LM, et al. Among authors: quercioli l. Eur Neuropsychopharmacol. 2001 Apr;11(2):169-72. doi: 10.1016/s0924-977x(01)00082-7. Eur Neuropsychopharmacol. 2001. PMID: 11313163 Clinical Trial.

4

Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.

Pallanti S, Quercioli L, Koran LM. Pallanti S, et al. Among authors: quercioli l. J Clin Psychiatry. 2002 Sep;63(9):796-801. J Clin Psychiatry. 2002. PMID: 12363120 Clinical Trial.

5

Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.

Pallanti S, Quercioli L, Bruscoli M. Pallanti S, et al. Among authors: quercioli l. J Clin Psychiatry. 2004 Oct;65(10):1394-9. doi: 10.4088/jcp.v65n1015. J Clin Psychiatry. 2004. PMID: 15491244 Clinical Trial.

6

Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines.

Pallanti S, Quercioli L. Pallanti S, et al. Among authors: quercioli l. Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):400-12. doi: 10.1016/j.pnpbp.2005.11.028. Epub 2006 Feb 28. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16503369 Review.

7

Smooth-pursuit eye movement and saccadic intrusions in obsessive-compulsive disorder.

Pallanti S, Grecu LM, Gangemi PF, Massi S, Parigi A, Arnetoli G, Quercioli L, Zaccara G. Pallanti S, et al. Among authors: quercioli l. Biol Psychiatry. 1996 Dec 1;40(11):1164-72. doi: 10.1016/s0006-3223(95)00607-9. Biol Psychiatry. 1996. PMID: 8931920 Clinical Trial.

8

Resistant social anxiety disorder response to Escitalopram.

Pallanti S, Quercioli L. Pallanti S, et al. Among authors: quercioli l. Clin Pract Epidemiol Ment Health. 2006 Dec 13;2:35. doi: 10.1186/1745-0179-2-35. Clin Pract Epidemiol Ment Health. 2006. PMID: 17166264 Free PMC article.

9

Cognitive event-related potentials differentiate schizophrenia with obsessive-compulsive disorder (schizo-OCD) from OCD and schizophrenia without OC symptoms.

Pallanti S, Castellini G, Chamberlain SR, Quercioli L, Zaccara G, Fineberg NA. Pallanti S, et al. Among authors: quercioli l. Psychiatry Res. 2009 Nov 30;170(1):52-60. doi: 10.1016/j.psychres.2008.11.002. Epub 2009 Oct 2. Psychiatry Res. 2009. PMID: 19800695

10

rTMS in resistant mixed states: an exploratory study.

Pallanti S, Grassi G, Antonini S, Quercioli L, Salvadori E, Hollander E. Pallanti S, et al. Among authors: quercioli l. J Affect Disord. 2014 Mar;157:66-71. doi: 10.1016/j.jad.2013.12.024. Epub 2013 Dec 28. J Affect Disord. 2014. PMID: 24581830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters